- Home
- SBSI vs PRTA Comparison
SBSI vs PRTA Comparison
Compare SBSI & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBSI
- PRTA
- Stock Information
- Founded
- SBSI 1960
- PRTA 2012
- Country
- SBSI United States
- PRTA Ireland
- Employees
- SBSI N/A
- PRTA N/A
- Industry
- SBSI Major Banks
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- SBSI Finance
- PRTA Health Care
- Exchange
- SBSI Nasdaq
- PRTA Nasdaq
- Market Cap
- SBSI 861.5M
- PRTA 809.8M
- IPO Year
- SBSI N/A
- PRTA N/A
- Fundamental
- Price
- SBSI $29.68
- PRTA $6.89
- Analyst Decision
- SBSI Hold
- PRTA Buy
- Analyst Count
- SBSI 2
- PRTA 9
- Target Price
- SBSI $37.00
- PRTA $51.71
- AVG Volume (30 Days)
- SBSI 111.7K
- PRTA 1.6M
- Earning Date
- SBSI 04-29-2025
- PRTA 05-08-2025
- Dividend Yield
- SBSI 4.84%
- PRTA N/A
- EPS Growth
- SBSI 7.94
- PRTA N/A
- EPS
- SBSI 2.91
- PRTA N/A
- Revenue
- SBSI $254,817,000.00
- PRTA $137,935,000.00
- Revenue This Year
- SBSI $10.28
- PRTA N/A
- Revenue Next Year
- SBSI $5.20
- PRTA $131.71
- P/E Ratio
- SBSI $10.22
- PRTA N/A
- Revenue Growth
- SBSI 6.49
- PRTA 54.55
- 52 Week Low
- SBSI $25.30
- PRTA $8.00
- 52 Week High
- SBSI $38.00
- PRTA $25.42
- Technical
- Relative Strength Index (RSI)
- SBSI 63.51
- PRTA 22.82
- Support Level
- SBSI $29.42
- PRTA $6.92
- Resistance Level
- SBSI $30.28
- PRTA $8.08
- Average True Range (ATR)
- SBSI 0.56
- PRTA 0.70
- MACD
- SBSI 0.21
- PRTA -0.03
- Stochastic Oscillator
- SBSI 77.86
- PRTA 2.15
About SBSI Southside Bancshares Inc.
Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).